F Brun-Vézinet

535 total citations
9 papers, 270 citations indexed

About

F Brun-Vézinet is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, F Brun-Vézinet has authored 9 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Virology, 4 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in F Brun-Vézinet's work include HIV Research and Treatment (4 papers), Herpesvirus Infections and Treatments (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). F Brun-Vézinet is often cited by papers focused on HIV Research and Treatment (4 papers), Herpesvirus Infections and Treatments (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). F Brun-Vézinet collaborates with scholars based in France, Netherlands and United States. F Brun-Vézinet's co-authors include C. Leport, Kevin M. De Cock, Philippe Flandre, Richard S. Tedder, Gerrit‐Jan Weverling, Steve Kaye, Remko van Leeuwen, Jolanda M.G.H. Tijnagel, Clive Loveday and Charles A. Boucher and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Human Reproduction.

In The Last Decade

F Brun-Vézinet

9 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Brun-Vézinet France 7 159 144 123 29 18 9 270
Marie-Christine Defer Burkina Faso 7 325 2.0× 146 1.0× 172 1.4× 14 0.5× 22 1.2× 10 444
Jean‐Baptiste Andonaba Burkina Faso 5 274 1.7× 125 0.9× 160 1.3× 11 0.4× 20 1.1× 9 373
Philip La Russa United States 5 218 1.4× 112 0.8× 119 1.0× 10 0.3× 49 2.7× 7 281
Douglas D. Richman United States 6 366 2.3× 136 0.9× 175 1.4× 9 0.3× 9 0.5× 6 451
B Clotet Spain 12 126 0.8× 71 0.5× 156 1.3× 22 0.8× 13 0.7× 24 318
Pierre MʼPelé France 11 181 1.1× 259 1.8× 301 2.4× 13 0.4× 19 1.1× 22 423
W Borkowsky United States 10 204 1.3× 270 1.9× 288 2.3× 18 0.6× 76 4.2× 19 441
Sherzana Sunderji Kenya 5 190 1.2× 171 1.2× 101 0.8× 18 0.6× 131 7.3× 6 416
K Murugavel India 12 124 0.8× 61 0.4× 140 1.1× 10 0.3× 14 0.8× 29 293
Samuel Martin Sosso Cameroon 11 133 0.8× 106 0.7× 177 1.4× 6 0.2× 32 1.8× 30 304

Countries citing papers authored by F Brun-Vézinet

Since Specialization
Citations

This map shows the geographic impact of F Brun-Vézinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Brun-Vézinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Brun-Vézinet more than expected).

Fields of papers citing papers by F Brun-Vézinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Brun-Vézinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Brun-Vézinet. The network helps show where F Brun-Vézinet may publish in the future.

Co-authorship network of co-authors of F Brun-Vézinet

This figure shows the co-authorship network connecting the top 25 collaborators of F Brun-Vézinet. A scholar is included among the top collaborators of F Brun-Vézinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Brun-Vézinet. F Brun-Vézinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Duval, Xavier, François Bissuel, Philippe Flandre, et al.. (2001). Salivary Cytomegalovirus (CMV) Shedding, Glycoprotein B Genotype Distribution, and CMV Disease in Human Immunodeficiency Virus–Seropositive Patients. Clinical Infectious Diseases. 33(8). 1406–1411. 41 indexed citations
2.
Letur-Könirsch, H, J.-L. Bénifla, A. Devaux, et al.. (1999). O-014. Viral risk and straw for cryopreservation: a preliminary experimental study with HIV 1. Human Reproduction. 14(Suppl_3). 8–8. 1 indexed citations
3.
Gérard, Laurence, C. Leport, Philippe Flandre, et al.. (1997). Cytomegalovirus (CMV) Viremia and the CD4+ Lymphocyte Count as Predictors of CMV Disease in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 24(5). 836–840. 48 indexed citations
4.
Schuurman, Rob, Diane Descamps, Gerrit‐Jan Weverling, et al.. (1996). Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. Journal of Clinical Microbiology. 34(12). 3016–3022. 93 indexed citations
5.
Loussert-Ajaka, Ibtissam, Fabrice Simon, Isabelle Farfara, et al.. (1993). Virological diagnosis of mixed HIV-1/HIV-2 infection.. PubMed. 6(11). 1284–5. 1 indexed citations
6.
Simon, François, et al.. (1992). Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. Journal of Clinical Microbiology. 30(11). 2917–2920. 27 indexed citations
7.
Cock, Kevin M. De, et al.. (1991). HIV-1 and HIV-2 infections and AIDS in West Africa.. PubMed. 5 Suppl 1. S21–8. 32 indexed citations
8.
Vildé, J. L., et al.. (1986). Comparative Trial of Acyclovir and Vidarabine in Disseminated Varicella‐Zoster Virus Infections in Immunocompromised Patients. Journal of Medical Virology. 20(2). 127–134. 14 indexed citations
9.
Montagnier, Luc, J C Chermann, Françoise Barré‐Sinoussi, et al.. (1984). Lymphadenopathy associated virus and its etiological role in AIDS.. PubMed. 15. 319–31. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026